Share on StockTwits

IPC The Hospitalist Company (NASDAQ: IPCM) received a number of ratings updates from brokerages and research firms in the last week:

  • IPC The Hospitalist Company had its “hold” rating reaffirmed by analysts at Citigroup Inc.. They now have a $50.00 price target on the stock.
  • IPC The Hospitalist Company had its price target lowered by analysts at Piper Jaffray from $57.00 to $49.00.
  • IPC The Hospitalist Company had its “neutral” rating reaffirmed by analysts at Credit Suisse. They now have a $50.00 price target on the stock.
  • IPC The Hospitalist Company had its “hold” rating reaffirmed by analysts at Deutsche Bank. They now have a $51.00 price target on the stock, down previously from $54.00.
  • IPC The Hospitalist Company had its “hold” rating reaffirmed by analysts at Jefferies Group. They now have a $48.00 price target on the stock, down previously from $57.00.
  • IPC The Hospitalist Company had its price target lowered by analysts at Dougherty & Co from $70.00 to $55.00. They now have a “buy” rating on the stock.
  • IPC The Hospitalist Company was upgraded by analysts at Wells Fargo & Co. from a “market perform” rating to an “outperform” rating.

Shares of IPC The Hospitalist Company Inc (NASDAQ:IPCM) opened at 40.26 on Friday. IPC The Hospitalist Company Inc has a 52 week low of $39.78 and a 52 week high of $63.70. The stock’s 50-day moving average is $47.92 and its 200-day moving average is $53.97. The company has a market cap of $689.7 million and a P/E ratio of 17.16.

IPC The Hospitalist Company, Inc (NASDAQ:IPCM) is a provider of hospitalist services in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.